Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Bamco Inc. NY bought a new stake in CareDx, Inc. (NASDAQ: CDNA) in the undefined quarter, according

CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.

CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforc

On June 30, 2026, Ron Baron (Trades, Portfolio) executed a significant reduction in the firm's posit

Five stocks, including CareDx and Caterpillar, cleared an efficiency screen based on key ratios exce

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagno

Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 r

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagno

CareDx is helping to improve outcomes for transplant patients. The health monitor's non-invasive tes

Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and mainta

CareDx, Inc. (CDNA) Q2 2026 Earnings Call Transcript

CareDx (CDNA) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estim

CareDx NASDAQ: CDNA reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics

Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus

CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagno

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings

Amova Asset Management Americas Inc. raised its holdings in shares of CareDx, Inc. (NASDAQ: CDNA) by

CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deepe

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The late

CareDx ($CDNA) shares surge 28% as Medicare finalizes continued coverage for its kidney, heart, and

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company in transplant, special

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagno

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnos

CDNA closes its Naveris buyout, adding NavDx and expanding its precision diagnostics reach into high

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused

CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o

CareDx, Inc.Common StockPreferred StockDebt SecuritiesWarrantsSubscription RightsUnits​We may offer

CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o

CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.34 per share which beat the analyst consensus

CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o

CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focus

U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 1

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused

Wells Fargo analyst Brandon Couillard maintains CareDx (NASDAQ:CDNA) with a Equal-Weight and rais

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.12 per share which missed the analyst consens